40
Participants
Start Date
February 28, 2024
Primary Completion Date
December 31, 2025
Study Completion Date
December 31, 2026
Nicotinamide Riboside Chloride
The intervention consists of 6 months to 1 year of daily oral therapy with Nicotinamide Riboside Chloride (Niagen) in addition to standard therapy.
Placebo
The intervention consists of 6 months to 1 year of daily oral therapy with placebo (Maltodextran capsules of similar size, shape and color as Niagen) in addition to standard therapy.
Standard of Care
Standard of Care
RECRUITING
UPMC Children's Hospital of Pittsburgh, Pittsburgh
Crohn's and Colitis Foundation
OTHER
University of Pittsburgh
OTHER